Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

PHAR 202 – Pharmacology II University of North Carolina, Exams of Pharmacology

PHAR 202 – Pharmacology II University of North Carolina

Typology: Exams

2024/2025

Available from 07/11/2025

lec-douglas-levis
lec-douglas-levis 🇺🇸

121 documents

1 / 8

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
PHAR 202 – Pharmacology II University of North Carolina at Chapel Hill (UNC)
Academic Year 2025-2026
Actual |acquisition |cost |- |answersactual |cost |to |the |pharmacy |of |purchasing |a |drug |product |from |a |
manufacturer/wholesaler
Benefit |- |answersitems |that |are |covered |by |an |insurer |(eg. |PharmaCare)
Beneficiary |- |answersperson |who |receives |benefits |from |an |insurer
Brand |name |- |answerstrademarked |name |for |a |specific |product |made |by |a |specific |manufacturer
Brand |product |- |answersproduct |made |by |the |company |that |did |the |original |research |to |develop |the |
product
Capitation |fee |- |answersper-person, |per-month |fee |(or |other |fixed |period) |for |services
Co-payment |- |answersportion |of |cost |paid |by |the |beneficiary |AFTER |insurance |begins |to |contribute
Deductible |- |answersportion |of |cost |paid |by |the |beneficiary |BEFORE |insurance |begins |to |contribute
Formulary |- |answerslist |of |medications
Generic |name |- |answersnon-trademarked |name |for |product |(not |specific |to |a |particular |
manufacturer)
Generic |product |- |answersproduct |made |by |a |company |that |didn't |do |the |original |research |to |develop
|the |product |- |it's |a |copy |of |the |brand |product
Generic |substitution |- |answersdispensing |a |generic |product |when |a |brand |product |has |been |
prescribed
Interchangeable |drugs |- |answersdrugs |with |same |active |ingredients, |similar |pharmacokinetic |
properties |and |the |same |clinically |significant |formulation |characteristics |(meant |to |be |administered |
the |same |way)
Limited |coverage |drug |- |answersproduct |the |requires |special |authority |to |be |a |PharmaCare |benefit
Low |cost |alternative |drug |- |answersinterchangeable |product |with |lowest |cost
Premiums |- |answersfees |to |belong |to |an |insurance |plan
Professional |fee |- |answersfee |charged |on |dispensed |Rxs |to |cover |the |pharmacist's |services
Reference |drug |- |answerscheapest |drug(s) |within |a |class/category |of |drugs |with |similar |therapeutic |
properties
Therapeutic |interchange |- |answersdispensing |an |alternate |drug |with |similar |therapeutic |properties |to |
the |drug |prescribed
pf3
pf4
pf5
pf8

Partial preview of the text

Download PHAR 202 – Pharmacology II University of North Carolina and more Exams Pharmacology in PDF only on Docsity!

PHAR 202 – Pharmacology II University of North Carolina at Chapel Hill (UNC)

Academic Year 2025-

Actual |acquisition |cost |- |answersactual |cost |to |the |pharmacy |of |purchasing |a |drug |product |from |a | manufacturer/wholesaler Benefit |- |answersitems |that |are |covered |by |an |insurer |(eg. |PharmaCare) Beneficiary |- |answersperson |who |receives |benefits |from |an |insurer Brand |name |- |answerstrademarked |name |for |a |specific |product |made |by |a |specific |manufacturer Brand |product |- |answersproduct |made |by |the |company |that |did |the |original |research |to |develop |the | product Capitation |fee |- |answersper-person, |per-month |fee |(or |other |fixed |period) |for |services Co-payment |- |answersportion |of |cost |paid |by |the |beneficiary |AFTER |insurance |begins |to |contribute Deductible |- |answersportion |of |cost |paid |by |the |beneficiary |BEFORE |insurance |begins |to |contribute Formulary |- |answerslist |of |medications Generic |name |- |answersnon-trademarked |name |for |product |(not |specific |to |a |particular | manufacturer) Generic |product |- |answersproduct |made |by |a |company |that |didn't |do |the |original |research |to |develop |the |product |- |it's |a |copy |of |the |brand |product Generic |substitution |- |answersdispensing |a |generic |product |when |a |brand |product |has |been | prescribed Interchangeable |drugs |- |answersdrugs |with |same |active |ingredients, |similar |pharmacokinetic | properties |and |the |same |clinically |significant |formulation |characteristics |(meant |to |be |administered | the |same |way) Limited |coverage |drug |- |answersproduct |the |requires |special |authority |to |be |a |PharmaCare |benefit Low |cost |alternative |drug |- |answersinterchangeable |product |with |lowest |cost Premiums |- |answersfees |to |belong |to |an |insurance |plan Professional |fee |- |answersfee |charged |on |dispensed |Rxs |to |cover |the |pharmacist's |services Reference |drug |- |answerscheapest |drug(s) |within |a |class/category |of |drugs |with |similar |therapeutic | properties Therapeutic |interchange |- |answersdispensing |an |alternate |drug |with |similar |therapeutic |properties |to | the |drug |prescribed

definition |- |answerscan |be |obtained |from |PC |to |obtain |additional |coverage |for |a |drug |when |there |is |a |clinically |important |reason |to |provide |a |patient |with |a |drug |for |which |coverage |is |normally |limited used |when |- |answers- |want |F |when |it's |P |in |LCA

  • |want |LCA |not |RDP |price |for |non |reference |drug |(therefore |want |F |for |P*) |in |RDP
  • |want |F/P |for |drugs |that |have |Y |in |SA |only |column |= |obtaining |full/partial |coverage |in |accordance | with |LCA/RDP |program
  • |coverage |for |cholinesterase |inhibitors |in |Alzheimer's |Drug |Therapy |initiative
  • |exemption |from | 30 |day |limit |on |PC |coverage |of |short |term |meds |for |ppl |who |live |2+ |hours |away | from |nearest |pharmacy how |to |get |- |answers- |practitioner |submits |form |to |PC |on |behalf |of |patient |that |says |= |drug |+ |clinical | rationale |for |use
  • |2-4 |weeks |for |approval, |not |applied |retroactively
  • |SA |can |have |expiry |date |or |for |indefinite |period
  • |often |need |specific |criteria cancer |treatment |drugs |- |answers- |provided |by |BC |Cancer |Agency transplant |medications |- |answers- |immunosuppresants |provided |by |BC |Transplant |through |designated |pharmacies |associated |with |transplant |clinics kidney |dialysis |drugs |- |answers- |individuals |registered |with |BC |Renal |Agency |through |designated | pharmacies |associated |with |dialysis |clinics
  • | 2 |formularies |= |1. |receiving |dialysis |2. |not |receiving |dialysis, |have |kidney |failure NIHB |Program |- |answers- |for |first |nations/inuit |people
  • |coverage |for |additional |products/services |incl. |some |prescription |drugs |+ |OTC |meds |(when | prescribed) |not |covered |by |PC
  • |coverage |for |some |drugs |on |list |can |be |obtained |with |prior |approval
  • |limited |to |low |cost |alternative |policy Fair |PharmaCare |- |answers-residents |of |BC |w/valid |MSP |coverage |+ |filed |an |income |tax |return | 2 |years |ago
  • |most |drugs |prescribed |by: |doctor, |surgeon, |dentist, |midwife, |NP, |opt., |pod. |+ |(insulin, |needles, | syringes, |blood |glucose |monitoring |strips |[for |those |w/valid |training |certificate], |insulin |pump |for | diabetic |adults |+ |children, |selected |ostomy |supplies, |selected |prosthetics |and |orthotics
  • |deductible/family |max |= |family |income |based
  • |copayment |= |depends |on |age |and |benefits |already |received |during |calendar |year
  • |d/cp |for |most |prescribed |meds |is |primary |plan |is |FPC, |but |not |for |drugs |on |Plan |formulary BC |Centre |for |Excellence |in |HIV/AIDS |- |answers- |enrolled |in |centre |by |physician, |have |HIV/AIDS
  • |normal |benefits |of |primary |plan |+ |antiretrovirals |and |other |meds |specific |for |HIV/AIDS
  • |d/cp |for |most |prescribed |meds |is |primary |plan |is |FPC, |but |not |for |prescribed |drugs |by |the |Centre Methadone |Maintenance |Program |- |answers- |residents |of |BC |with |opioid |dependance
  • |normal |benefits |of |primary |plan |+ |methadone
  • |d/cp |for |most |prescribed |meds |is |primary |plan |is |FPC
  • |for |methadone, |AAC |+ |professional |fee |to |max |allowed, |plus |interaction |fee |where |appropriate Fair |PharmaCare |applies |to |- |answersresidents |of |BC |with |valid |MSP |coverage |and |who |have |filed |an | income |tax |return | 2 |years |ago Through |FPC |you |can |get |drugs |prescribed |by |- |answersdoctor, |surgeon, |dentist, |midwife, |nurse | practitioner, |optometrist |and |podiatrist Extra |benefits |of |FPC |(7) |- |answersInsulin, |needles, |syringes, |blood |glucose |monitoring |strips |[for | those |with |valid |training |certificate], |insulin |pump |for |diabetic |adults |and |children, |selected |ostomy | supplies, |selected |prosthetics |and |orthotics Plan |B |applies |to |- |answerspermanent |residents |of |licensed |residential |care |facilities |in |BC Additional |benefits |of |Plan |B |- |answersDrugs |covered |for |Plan |B |only Alternative |to |a |professional |fee |in |Plan |B |- |answersPharmacy |receives |a |fixed |monthly |fee |for |each | resident |in |the |facility Plan |C |applies |to |- |answersresidents |of |BC |who |are |receiving |medical |benefits |as |part |of |their | assistance |from |the |Ministry |of |Housing |and |Social |Development Additional |benefits |of |Plan |C |- |answersbenefits |approved |by |Ministry |staff |when |considered |essential | to |health |(nutritional |supplements |and |prenatal |vitamins |for |example) ad |- |answersto, |up |to ad. |lib. |- |answersat |pleasure agit. |- |answersshake, |stir alb. |- |answerswhite aa |- |answersof |each a. |- |answersbefore a.c. |- |answersbefore |meals a.m. |- |answersin |the |morning

aq. |- |answerswater a.u. |- |answerseach |ear a.d. |- |answersright |ear a.l. |- |answersleft |ear a.s. |- |answersleft |ear b.d.s. |- |answerstwice |a |day b.i.d. |- |answerstwice |a |day b.d. |- |answerstwice |a |day caps. |- |answerscapsule collun. |- |answersnose |wash collut. |- |answersmouth |wash collyr. |- |answerseye |wash contra |- |answersagainst c. |(-) |- |answerswith c.c. |(first |is |-) |- |answerswith |meals d. |- |answersright/day/dose dieb. |alt. |- |answersevery |other |day dil. |- |answersdilute emuls. |- |answersemulsion et |- |answersand ex |- |answerswith ex |aqua |- |answerswith |water F. |- |answersmake Ft. |- |answersmake fort. |- |answersstrong garg. |- |answers(a) |gargle gr. |- |answersgrain(s) gtt. |- |answersdrop h. |- |answershour

o.l. |- |answersleft |eye o.s. |- |answersleft |eye o. |- |answerseach, |every o.d. |- |answersevery |day os |- |answersmouth oris |- |answersmouth per |os |- |answersorally p. |- |answersafter p.c. |- |answersafter |meals p.m. |- |answersafternoon/evening p.r.n. |- |answerswhen |necessary pulv. |- |answerspowder q. |- |answerseach/every q.d. |- |answersevery |day q.s. |- |answersas |much |as |is |sufficient q.i.d. |- |answers4 |times |a |day q.d.s. |- |answers4 |times |a |day Rx |- |answerstake rept. |- |answerslet |it |be |repeated s.o.s. |- |answersif |necessary Sig. |- |answersmark |thou s.(-) |- |answerswithout sat. |sol. |- |answerssaturated |solution S.V.R. |- |answersrectified |spirit |of |alcohol stat. |- |answersimmediately supp. |- |answerssuppository tab. |- |answerstablet t.d.s. |- |answers3 |times |a |day t.i.d. |- |answers3 |times |a |day

t.d. |- |answers3 |times |a |day tr. |- |answerstincture ung. |- |answersointment ut |dict. |- |answersas |directed u.d. |- |answersas |directed a.t.c. |- |answersaround |the |clock d.n.s. |- |answersdo |not |substitute i.m. |- |answersintramuscular i.v. |- |answersintravenous p.r. |- |answersrectally p.v. |- |answersvaginally s.c. |- |answerssubcutaneous s.l. |- |answerssublingual w.a. |- |answerswhile |awake